Rolph Timothy
Insider CIK 1779479 · AKRO Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 389 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 49,945 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 29,074 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 29,074 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,152 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 84,051 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 119,969 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 56,579 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 2,328 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 5,032 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,421 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 238,339 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 43,810 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-11-25 | 2025-11-28 | 43,064 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-11-25 | 2025-11-28 | 3,527 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-11-25 | 2025-11-28 | 4,284 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-11-25 | 2025-11-28 | 4,739 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-11-25 | 2025-11-28 | 94,268 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-11-25 | 2025-11-28 | 2,796 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-11-25 | 2025-11-28 | 2,796 | $0.62 | $1.7K | 183,142 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-11-25 | 2025-11-28 | 3,527 | $28.35 | $100.0K | 132,998 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-11-25 | 2025-11-28 | 43,064 | $6.36 | $273.9K | 176,062 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-11-25 | 2025-11-28 | 4,284 | $21.09 | $90.3K | 180,346 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-11-25 | 2025-11-28 | 94,268 | $0.62 | $58.4K | 277,410 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-11-25 | 2025-11-28 | 4,739 | $21.10 | $100.0K | 282,149 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | G Gift | 2025-11-17 | 2025-11-19 | 37,100 | — | $0 | 129,471 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-10-07 | 2025-10-09 | 12,500 | — | $0 | 49,945 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-10-07 | 2025-10-09 | 1,037 | $46.82 | $48.6K | 166,571 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-10-07 | 2025-10-09 | 11,463 | $46.01 | $527.4K | 167,608 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-10-07 | 2025-10-09 | 12,500 | $28.35 | $354.4K | 179,071 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-09-11 | 2025-09-12 | 553 | $43.02 | $23.8K | 166,571 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-09-08 | 2025-09-10 | 295 | — | $0 | 62,445 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-09-08 | 2025-09-10 | 5,161 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-09-08 | 2025-09-10 | 7,044 | — | $0 | 389 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-09-08 | 2025-09-10 | 295 | $28.35 | $8.4K | 179,624 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-09-08 | 2025-09-10 | 7,044 | $21.09 | $148.6K | 174,168 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-09-08 | 2025-09-10 | 12,466 | $44.17 | $550.6K | 167,158 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-09-08 | 2025-09-10 | 34 | $44.88 | $1.5K | 167,124 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-09-08 | 2025-09-10 | 5,161 | $6.36 | $32.8K | 179,329 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-08-05 | 2025-08-07 | 12,500 | — | $0 | 7,433 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-08-05 | 2025-08-07 | 6,962 | $49.49 | $344.5K | 167,124 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-08-05 | 2025-08-07 | 5,538 | $49.07 | $271.7K | 174,086 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-08-05 | 2025-08-07 | 12,500 | $21.09 | $263.6K | 179,624 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-07-07 | 2025-07-09 | 12,500 | — | $0 | 19,933 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-07-07 | 2025-07-09 | 10,634 | $50.93 | $541.6K | 168,990 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-07-07 | 2025-07-09 | 12,500 | $21.09 | $263.6K | 179,624 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-07-07 | 2025-07-09 | 1,825 | $52.00 | $94.9K | 167,165 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-07-07 | 2025-07-09 | 41 | $52.62 | $2.2K | 167,124 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2025-06-30 | 2025-07-02 | 890 | $23.87 | $21.2K | 167,124 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-18 | 2025-06-20 | 1,129 | $54.84 | $61.9K | 166,234 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-10 | 2025-06-12 | 2,358 | $54.00 | $127.3K | 167,363 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-06-06 | 2025-06-09 | 24,611 | — | $0 | 32,433 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-06-06 | 2025-06-09 | 389 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-06-06 | 2025-06-09 | 24,611 | $21.09 | $519.0K | 194,332 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-06-06 | 2025-06-09 | 389 | $21.10 | $8.2K | 194,721 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-06 | 2025-06-09 | 25,000 | $55.04 | $1.38M | 169,721 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-06-05 | 2025-06-09 | 12,500 | — | $0 | 389 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-05 | 2025-06-09 | 9,350 | $53.37 | $499.0K | 172,871 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-05 | 2025-06-09 | 3,150 | $53.84 | $169.6K | 169,721 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-06-05 | 2025-06-09 | 12,500 | $21.10 | $263.8K | 182,221 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-05-06 | 2025-05-08 | 12,500 | — | $0 | 12,889 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-05-06 | 2025-05-08 | 300 | $44.50 | $13.3K | 169,721 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-05-06 | 2025-05-08 | 12,500 | $21.10 | $263.8K | 182,221 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-05-06 | 2025-05-08 | 3,550 | $42.26 | $150.0K | 178,671 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-05-06 | 2025-05-08 | 8,650 | $43.87 | $379.5K | 170,021 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-04-24 | 2025-04-28 | 3,684 | — | $0 | 25,389 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-04-24 | 2025-04-28 | 2,566 | — | $0 | 26,152 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-04-24 | 2025-04-28 | 6,250 | $41.03 | $256.4K | 169,721 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-04-24 | 2025-04-28 | 6,250 | $21.10 | $131.9K | 175,971 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-04-07 | 2025-04-10 | 6,250 | — | $0 | 28,718 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-04-07 | 2025-04-10 | 100 | $36.93 | $3.7K | 169,921 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-04-07 | 2025-04-10 | 3,750 | $36.05 | $135.2K | 170,021 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-04-07 | 2025-04-10 | 2,200 | $35.36 | $77.8K | 173,771 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-04-07 | 2025-04-10 | 200 | $37.92 | $7.6K | 169,721 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-04-07 | 2025-04-10 | 6,250 | $21.10 | $131.9K | 175,971 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-03-12 | 2025-03-14 | 516 | $44.88 | $23.2K | 169,721 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-03-05 | 2025-03-07 | 12,500 | — | $0 | 34,968 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-03-05 | 2025-03-07 | 9,338 | $44.40 | $414.6K | 173,399 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-03-05 | 2025-03-07 | 12,500 | $21.10 | $263.8K | 182,737 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-03-05 | 2025-03-07 | 3,162 | $44.90 | $142.0K | 170,237 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-02-05 | 2025-02-07 | 18,750 | — | $0 | 47,468 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-02-05 | 2025-02-07 | 18,750 | $21.10 | $395.6K | 188,987 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-02-05 | 2025-02-07 | 5,903 | $56.92 | $336.0K | 170,237 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-02-05 | 2025-02-07 | 12,847 | $56.33 | $723.7K | 176,140 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-01-27 | 2025-01-29 | 14,986 | — | $0 | 119,969 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-01-27 | 2025-01-29 | 16,264 | — | $0 | 66,218 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-01-27 | 2025-01-29 | 16,264 | $21.10 | $343.2K | 201,487 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-01-27 | 2025-01-29 | 14,986 | $19.87 | $297.8K | 185,223 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-01-27 | 2025-01-29 | 12,379 | $56.97 | $705.2K | 170,237 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-01-27 | 2025-01-29 | 5,059 | $55.62 | $281.4K | 182,616 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-01-27 | 2025-01-29 | 13,812 | $54.76 | $756.3K | 187,675 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | G Gift | 2025-01-07 | 2025-01-10 | 14,000 | — | $0 | 170,237 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | G Gift | 2024-12-26 | 2024-12-30 | 14,100 | — | $0 | 184,237 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-12-17 | 2024-12-18 | 3,800 | — | $0 | 134,955 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-12-17 | 2024-12-18 | 3,800 | $31.10 | $118.2K | 178,337 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-12-17 | 2024-12-18 | 3,800 | $19.87 | $75.5K | 182,137 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2024-12-16 | 2024-12-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2024-12-16 | 2024-12-18 | 20,000 | — | $0 | 198,337 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-12-10 | 2024-12-12 | 2,450 | — | $0 | 138,755 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-12-10 | 2024-12-12 | 2,450 | $19.87 | $48.7K | 180,787 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-12-10 | 2024-12-12 | 2,450 | $31.03 | $76.0K | 178,337 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-12-10 | 2024-12-12 | 2,368 | $30.79 | $72.9K | 178,337 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-13 | 537 | $26.18 | $14.1K | 180,705 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2024-06-28 | 2024-07-02 | 1,064 | $19.94 | $21.2K | 181,242 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-06-11 | 2024-06-13 | 2,380 | $22.64 | $53.9K | 180,178 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-03-13 | 2024-03-15 | 619 | $28.33 | $17.5K | 182,558 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-12-14 | 2023-12-18 | 514 | $20.76 | $10.7K | 182,672 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2023-12-08 | 2023-12-12 | 146,237 | — | $0 | 146,237 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2023-12-08 | 2023-12-12 | 32,497 | — | $0 | 183,186 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-09-13 | 2023-09-25 | 531 | $50.34 | $26.7K | 150,689 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-06-16 | 2023-06-21 | 40,000 | — | $0 | 2,796 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-06-16 | 2023-06-21 | 40,000 | $0.61 | $24.4K | 229,420 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-16 | 2023-06-21 | 49,325 | $54.58 | $2.69M | 180,095 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-16 | 2023-06-21 | 1,413 | $56.30 | $79.6K | 151,220 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-16 | 2023-06-21 | 27,462 | $55.08 | $1.51M | 152,633 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-13 | 2023-06-15 | 509 | $55.16 | $28.1K | 189,420 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | F Tax w/h | 2023-03-10 | 2023-03-14 | 603 | $43.47 | $26.2K | 189,929 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-12-29 | 2022-12-30 | 7,816 | — | $0 | 66,267 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-12-29 | 2022-12-30 | 12,293 | $51.38 | $631.6K | 190,532 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-12-29 | 2022-12-30 | 8,023 | $50.55 | $405.6K | 202,825 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-12-29 | 2022-12-30 | 7,816 | $28.35 | $221.6K | 210,848 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-12-28 | 2022-12-30 | 1,700 | — | $0 | 74,083 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-12-28 | 2022-12-30 | 1,700 | $50.00 | $85.0K | 203,032 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-12-28 | 2022-12-30 | 1,700 | $28.35 | $48.2K | 204,732 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-12-16 | 2022-12-20 | 29,073 | — | $0 | 87,221 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-12-09 | 2022-12-13 | 86,379 | — | $0 | 86,379 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2022-12-09 | 2022-12-13 | 19,195 | — | $0 | 203,032 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-11-16 | 2022-11-16 | 3,847 | $45.45 | $174.8K | 183,937 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-11-16 | 2022-11-16 | 100 | $46.05 | $4.6K | 183,837 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-11-15 | 2022-11-16 | 3,138 | $45.04 | $141.3K | 187,784 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-10-26 | 2022-10-27 | 4,762 | $45.03 | $214.4K | 190,922 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-10-25 | 2022-10-27 | 8,203 | — | $0 | 48,225 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-10-25 | 2022-10-27 | 1,797 | — | $0 | 75,783 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-10-25 | 2022-10-27 | 8,203 | $6.36 | $52.2K | 204,540 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-10-25 | 2022-10-27 | 1,797 | $28.35 | $50.9K | 206,337 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-10-25 | 2022-10-27 | 10,653 | $45.09 | $480.3K | 195,684 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-10-06 | 2022-10-07 | 10,000 | — | $0 | 61,328 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-10-06 | 2022-10-07 | 10,000 | $21.09 | $210.9K | 208,837 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-10-06 | 2022-10-07 | 22,500 | $39.29 | $884.0K | 186,337 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-09-30 | 2022-10-04 | 6,328 | — | $0 | 66,428 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-09-30 | 2022-10-04 | 13,672 | — | $0 | 71,328 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-09-30 | 2022-10-04 | 6,328 | $6.36 | $40.2K | 230,165 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-09-30 | 2022-10-04 | 22,500 | $31.38 | $706.0K | 221,337 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-09-30 | 2022-10-04 | 22,500 | $34.06 | $766.4K | 198,837 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-09-30 | 2022-10-04 | 13,672 | $21.09 | $288.3K | 243,837 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-09-13 | 2022-10-27 | 10,000 | — | $0 | 62,756 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-09-13 | 2022-10-27 | 22,500 | $29.18 | $656.5K | 233,837 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-09-13 | 2022-10-27 | 10,000 | $6.36 | $63.6K | 256,337 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-09-13 | 2022-09-13 | 29,074 | — | $0 | 58,148 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-09-13 | 2022-09-15 | 22,500 | $29.18 | $656.5K | 223,837 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-09-09 | 2022-09-13 | 29,074 | — | $0 | 29,074 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2022-06-30 | 2022-09-13 | 1,152 | $8.03 | $9.3K | 246,337 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2021-12-08 | 2021-12-10 | 87,221 | — | $0 | 87,221 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2021-06-30 | 2022-09-13 | 1,007 | $21.09 | $21.2K | 245,185 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2020-12-08 | 2020-12-09 | 77,580 | — | $0 | 77,580 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2020-06-30 | 2020-12-09 | 1,245 | $17.07 | $21.3K | 244,178 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2020-03-12 | 2020-03-13 | 27,368 | — | $0 | 94,268 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2020-03-12 | 2020-03-13 | 22,656 | — | $0 | 42,796 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2020-03-12 | 2020-03-13 | 27,368 | $0.61 | $16.7K | 220,277 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2020-03-12 | 2020-03-13 | 22,656 | $0.61 | $13.8K | 242,933 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2019-12-13 | 2019-12-13 | 85,000 | — | $0 | 85,000 | SEC↗ |